X
All Data
Upload your Marketing & Sales content on your company Virtual Booth, click HERE
Lead Product(s): OPC1
Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: OPC1
Highest Development Status: Phase I/ Phase II Product Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Lineagen
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement February 08, 2021
Details:
Lineage and Neurgain will collaborate on the clinical testing of Neurgain’s novel Parenchymal Delivery Injection system, OPC1 , which is designed to allow for the administration of cells to the spinal cord without stopping the patient’s respiration.
Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace
News Type
